Teligent
TLGT
#10190
Rank
HK$0.12 B
Marketcap
HK$1.33
Share price
-13.85%
Change (1 day)
1,609.91%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Revenue for Teligent (TLGT)

Revenue in 2021 (TTM): HK$0.35 Billion

According to Teligent's latest financial reports the company's current revenue is HK$0.36 Billion. In 2020 the company made a revenue of HK$0.35 Billion a decrease over the revenue in the year 2019 that were of HK$0.51 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Teligent from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)HK$0.35 B1.46%
2020HK$0.35 B-31.24%
2019HK$0.51 B-0.71%
2018HK$0.51 B-1.31%
2017HK$0.52 B0.55%
2016HK$0.52 B51.14%
2015HK$0.34 B31.15%
2014HK$0.26 B85.15%
2013HK$0.14 B112.81%
2012HK$66.91 M9.7%
2011HK$61 M28.07%
2010HK$47.63 M61.33%
2009HK$29.52 M-7.15%
2008HK$31.79 M-11.18%
2007HK$35.79 M74.85%
2006HK$20.47 M-8.62%
2005HK$22.4 M-8.84%
2004HK$24.57 M-11.58%
2003HK$27.79 M-51.95%
2002HK$57.85 M-54.52%
2001HK$0.12 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
HK$5.01 B 1,286.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
HK$1.76 M-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA